(Press-News.org) First produced only in the past decade, human induced pluripotent stem cells (iPSCs) are capable of developing into many or even all human cell types. In new research, scientists reprogrammed skin cells from patients with rare blood disorders into iPSCs, highlighting the great promise of these cells in advancing understanding of those challenging diseases—and eventually in treating them.
"The technology for generating these cells has been moving very quickly," said hematologist Mitchell J. Weiss, M.D., Ph.D., corresponding author of two recent studies led by The Children's Hospital of Philadelphia (CHOP). "These investigations can allow us to better understand at a molecular level how blood cells go wrong in individual patients—and to test and generate innovative treatments for the patients' diseases."
Weiss, with Monica Bessler, M.D., Philip Mason, Ph.D., and Deborah L. French, Ph.D., all of CHOP, led a study on iPSCs and Diamond Blackfan anemia (DBA) published online June 6 in Blood. Another study by Weiss, French and colleagues in the same journal on April 25 focused on iPSCs in juvenile myelomonocytic leukemia (JMML).
In DBA, a mutation prevents a patient's bone marrow from producing normal quantities of red blood cells, resulting in severe, sometimes life-threatening anemia. This basic fact makes it difficult for researchers to discern the underlying mechanism of the disease: "It's very difficult to figure out what's wrong, because the bone marrow is nearly empty of these cells," said Bessler, the director of CHOP's Pediatric and Adult Comprehensive Bone Marrow Failure Center.
The study team removed fibroblasts (skin cells) from DBA patients, and in cell cultures, using proteins called transcription factors, reprogrammed the cells into iPSCs. As those iPSCs were stimulated to form blood tissues, like the patient's original mutated cells, they were deficient in producing red blood cells.
However, when the researchers corrected the genetic defect that causes DBA, the iPSCs developed into red blood cells in normal quantities. "This showed that in principle, it's possible to repair a patient's defective cells," said Weiss.
Weiss cautioned that this proof-of-principle finding is an early step, with many further studies to be done to verify if this approach will be safe and effective in clinical use.
However, he added, the patient-derived iPSCs are highly useful as a model cell system for investigating blood disorders. For instance, DBA is often puzzling, because two family members may have the same mutation, but only one may be affected by the disease. Because each set of iPSCs is specific to the individual from whom they are derived, researchers can compare the sets to identify molecular differences, such as a modifier gene active in one person but not the other.
Furthermore, the cells offer a renewable, long-lasting model system for testing drug candidates or gene modifications that may offer new treatments, personalized to individual patients.
The second study in Blood provides a concrete example of using iPSCs for drug testing, specifically for the often-aggressive childhood leukemia, JMML. First the study team generated iPSCs from two children with JMML, and then manipulated the iPSCs in cell cultures to produce myeloid cells that multiplied uncontrollably, much as the original JMML cells do.
They then tested the cells with two drugs, each able to inhibit a separate protein known to be highly active in JMML. One drug, an inhibitor of the MEK kinase, reduced the proliferation of cancerous cells in culture. "This provides a rationale for a potential targeted therapy for this specific subtype of JMML," said Weiss.
A stem cell core facility at CHOP, directed by study co-author Deborah French under the auspices of the hospital's Center for Cellular and Molecular Therapeutics, generated the iPSCs lines used in these studies. The facility's goal is to develop and maintain standardized iPSCs lines specific to a variety of rare inherited diseases—not only DBA and JMML, but also dyskeratosis congenita, congenital dyserythropoietic anemia, thrombocytopenia absent radii (TAR), Glanzmann's thrombasthenia and Hermansky- Pudlak syndrome.
A longer-term goal, added Weiss, is for the iPSC lines to provide the raw materials for eventual cell therapies that could be applied to specific genetic disorders. "The more we learn about the molecular details of how these diseases develop, the closer we get to designing precisely targeted tools to benefit patients."
INFORMATION:
The National Institutes of Health (grants HL101606, DK090969) supported both studies. Also supporting the Diamond Blackfan anemia study were the U.S. Department of Defense (grant BM090168), and N.I.H. grants CA106995, CA105312, RR024134, and TR000003. Other funders of the JMML study were N.I.H. grants HL099656 and CA082103, the Cookies for Kids' Cancer Foundation, the Leukemia and Lymphoma Society and the Frank A. Campini Foundation. Weiss's research on stem cells is also supported by the Jane Fishman Grinberg Endowed Chair and Bessler receives support from the Buck Family Endowed Chair in Hematology.
"Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients," Blood, published online June 6, 2013. http://doi.org/10.1182/blood-2013-01-478321
"Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia," Blood, published online April 25, 2013. http://doi.org/10.1182/blood-2013-01-478412
About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program receives the highest amount of National Institutes of Health funding among all U.S. children's hospitals. In addition, its unique family-centered care and public service programs have brought the 527-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.
END
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a report demonstrating that unprocessed, raw cotton has an amazing ability to sop up oil while also being eco-friendly.
Based on a report by Seshadri Ramkumar, Ph.D., in the ACS journal Industrial & Engineering Chemistry Research, the new podcast is available without charge at iTunes and from http://www.acs.org/globalchallenges.
In light of the 2010 Deepwater Horizon disaster, Ramkumar notes that a particular need exists for oil-spill ...
Does life exist elsewhere or is our planet unique, making us truly alone in the universe? Much of the work carried out by NASA, together with other research institutions, is aimed at trying to come to grips with this question.
A novel and potentially testable theory of how life arose on earth, first advanced more than 25 years ago by Michael Russell, a research scientist in Planetary Chemistry and Astrobiology at the NASA Jet Propulsion Laboratory, was further developed in a recent paper published in Philosophical Transactions of the Royal Society B (PTRSL-B)—the world's ...
About half of a small group of patients with fibromyalgia – a common syndrome that causes chronic pain and other symptoms – was found to have damage to nerve fibers in their skin and other evidence of a disease called small-fiber polyneuropathy (SFPN). Unlike fibromyalgia, which has had no known causes and few effective treatments, SFPN has a clear pathology and is known to be caused by specific medical conditions, some of which can be treated and sometimes cured. The study from Massachusetts General Hospital (MGH) researchers will appear in the journal Pain and has been ...
A technique for trapping the greenhouse gas carbon dioxide deep underground could at the same be used to release the last fraction of natural gas liquids from ailing reservoirs, thus offsetting some of the environmental impact of burning fossil fuels. So says a paper to be published in the peer-reviewed International Journal of Oil, Gas and Coal Technology.
While so-called "fracking" as a method for extracting previously untapped fossil fuel reserves has been in the headlines recently, there are alternatives to obtaining the remaining quantities of hydrocarbons from gas/condensate ...
Santa's workshop at the North Pole is not under water, despite recent reports. A dramatic image captured by a University of Washington monitoring buoy reportedly shows a lake at the North Pole. But Santa doesn't yet need to buy a snorkel.
"Every summer when the sun melts the surface the water has to go someplace, so it accumulates in these ponds," said Jamie Morison, a polar scientist at the UW Applied Physics Laboratory and principal investigator since 2000 of the North Pole Environmental Observatory. "This doesn't look particularly extreme."
After media coverage in ...
Writer: Emil Venere, (765) 494-4709, venere@purdue.edu
Sources: Shirley Dyke, 765-494-7434, sdyke@purdue.edu
Related Web sites:
NEES: http://www.nees.org
PHOTO CAPTION:
Earthquake-engineering researches at the Harbin Institute of Technology in China work to set up a structure on a shake table for experiments to study the effects of earthquakes. Purdue University civil engineering students are working with counterparts at the institute to study the reliability of models for testing a type of powerful damping system that might be installed in buildings and bridges ...
It might be easier than previously thought for a planet to overheat into the scorchingly uninhabitable "runaway greenhouse" stage, according to new research by astronomers at the University of Washington and the University of Victoria published July 28 in the journal Nature Geoscience.
In the runaway greenhouse stage, a planet absorbs more solar energy than it can give off to retain equilibrium. As a result, the world overheats, boiling its oceans and filling its atmosphere with steam, which leaves the planet glowing-hot and forever uninhabitable, as Venus is now.
One ...
An international collaboration of researchers including Felicia Goodrum of the University of Arizona's immunobiology department has studied how a human herpes virus carried by the majority of the population packages its genetic information during infection.
The discoveries improve the chances of developing more targeted therapies in place of existing drugs, which do not always work or come with side effects.
Experts estimate that 60 to 90 percent of the world's population carry the human cytomegalovirus, or CMV, which is one of the eight herpes viruses that infect humans.
In ...
Tropical Storm Flossie weakened as it interacted with the Hawaiian Islands and became a depression. NASA's TRMM satellite saw mostly light rain and one isolated area of heavy rainfall within the storm after it weakened. All watches and warnings were dropped for the Hawaiian Islands on July 30.
The Tropical Rainfall Measuring Mission, or TRMM, satellite flew over Flossie on July 30 at 07:17 UTC (3:17 a.m. EDT) and saw a small area of heavy rain west of the center of circulation. TRMM data showed that the rest of Flossie's rainfall was light to moderate. TRMM is managed ...
Former Tropical Storm Dorian has been hanging around the Caribbean Sea for a couple of days, and appears stretched out on satellite imagery.
NOAA's GOES-13 satellite has been capturing images of the movement of Dorian since it was born. NASA's GOES Project at the NASA Goddard Space Flight Center in Greenbelt, Md. created an image of the storm using GOES-13 satellite data on July 30 at 1415 UTC/10:15 a.m. EDT. Dorian's remnants appear elongated from north to south on the GOES-13 image. The showers and thunderstorms are disorganized and extend a few hundred miles east ...
